Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer

Ottawa Hospital Research Institute37 enrolled

Overview

This study will compare two different methods of staging lung cancer to determine whether endobronchial ultrasound (EBUS) staging of mediastinal lymph nodes will provide good diagnostic yield in detecting lung cancer, when compared to current methods of a staging bronchoscopy and cervical mediastinoscopy.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Lung Cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: Patients, \> 18 years of age, Gender- Males and Female Diagnosis of Non Small Cell Lung Cancer. Patients who have consented on an Ottawa Hospital consent form to undergo a mediastinoscopy procedure or EBUS-TBNA, and a Positron emission tomography (PET) of the chest for lung cancer staging. Exclusion Criteria: Females who are pregnant (or found to be pregnant) during the course of this research study. Patients who do not provide their Ottawa Hospital consent to undergo a staging bronchoscopy , cervical mediastinoscopy or EBUS-TBNA.

Locations (1)

Ottawa Hospital Research Institute

Ottawa, Ontario, Canada

Outcomes

Primary Outcomes

Lung cancer staging

Lung cancer staging (assessed by either cervical mediastinoscopy or EBUS) will be compared both pre-op and post-op.

Time frame: Pre-op and post-op

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.